By: ChinaBio® Today
December 27, 2012 at 07:40 AM EST
“Major” China Biopharma Buys Bayer's Bay-Area Biopharma Campus
A major, though as-yet unnamed, China biopharma has bought the prestigious San Francisco-area biotech campus that formerly belonged to Bayer. The six-building campus is located in Richmond, on the Berkeley side of the bay. The buyer has promised to disclose its identity and plans for the site next month. One source hints the company will seek to set up a biopharma hub, a US base for itself and other China biopharmas, rather than occupy the entire space itself. Whatever the plans turn out to be, the purchase signals a new phase in the relationship between US and China biopharmas. The purchase price was not disclosed. More details.... Stock Symbol: (Xetra: BAY) Share this with colleagues: // //
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here